WallStreetZenWallStreetZen

NASDAQ: TRVI
Trevi Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TRVI earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$29.1M
Current Profit Margin
0%

TRVI Return on Equity

Current Company
-31.5%
Current Industry
-63.5%
Current Market
188%
TRVI's Return on Equity (-31.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TRVI announces earnings.

TRVI Return on Assets

Current Company
-28.9%
Current Industry
2.9%
TRVI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TRVI Return on Capital Employed

Current Company
-34.35%
Current Industry
19.5%
TRVI has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TRVI vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TRVI$0.00-$28.58M-$29.07MN/AN/A
NBTX$7.17M-$45.55M-$62.54M+61.58%N/A
ABEO$3.50M-$50.57M-$54.19M+3.14%N/A
CDXS$70.14M-$66.25M-$76.24M+2.97%N/A
CMPX$0.00-$40.60M-$42.49MN/AN/A
View Top Biotech Stocks

TRVI earnings dates

Next earnings date
May 9, 2024

Trevi Therapeutics Earnings & Revenue FAQ

What were TRVI's earnings last quarter?

On Invalid Date, Trevi Therapeutics (NASDAQ: TRVI) reported Q4 2023 earnings per share (EPS) of -$0.08, up 700% year over year. Total Trevi Therapeutics earnings for the quarter were -$7.82 million. In the same quarter last year, Trevi Therapeutics's earnings per share (EPS) was -$0.01.

If you're new to stock investing, here's how to buy Trevi Therapeutics stock.

What was TRVI's earnings growth in the past year?

As of Q2 2024, Trevi Therapeutics's earnings has grown year over year. Trevi Therapeutics's earnings in the past year totalled -$29.07 million.

What is TRVI's earnings date?

Trevi Therapeutics's earnings date is Invalid Date. Add TRVI to your watchlist to be reminded of TRVI's next earnings announcement.

What was TRVI's revenue last quarter?

On Invalid Date, Trevi Therapeutics (NASDAQ: TRVI) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Trevi Therapeutics's revenue was $0.00.

What was TRVI's revenue growth in the past year?

As of Q2 2024, Trevi Therapeutics's revenue has grown null year over year. Trevi Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.